• Email Us: [email protected]
  • Contact Us: +1 718 874 1545
  • Skip to main content
  • Skip to primary sidebar

Medical Market Report

  • Home
  • All Reports
  • About Us
  • Contact Us

Teatis, low-sugar superfood powders developer for diabetics, closes seed round

September 9, 2021 by David Barret Leave a Comment

A serial entrepreneur Hiroshi Takatoh recognized the need for convenient and nutritious food for critically ill consumers after losing his late wife to cancer.

Takatoh founded Teatis, a plant-based sugar blocking superfood powder for diabetic consumers, in 2017 in stealth mode and went fully operational in April 2021 by teaming up with a group of doctors and registered nutritionists.

Teatis announced today it has raised $700,000 seed funding to advance its growth in the US market.  The seed money brings Teatis’ total funding to over $1million.

The seed round was led by Genesia Ventures, Ryo Ishizuka, a former CEO and co-founder of Japanese e-commerce company Mercari and Takuya Noguchi, CEO and founder of Japan’s skincare brand BULK HOMME. Seven other angel investors also participated in the seed funding.

Teatis will use the seed money for production and marketing in the US, where 122 million diabetics and pre-diabetics continue to work for prevention and treatment against diabetes, CEO and co-founder of Teatis Hiroshi Takatoh told TechCrunch. The company is now focusing on the US market where its production is located while its next funding, a Series A, is set for next year, Takatoh added.

“Most of our consumers, about 88%, are diabetics, and our recipe is built to help diabetics manage their blood sugar. A staggering number of Americans suffer from diabetes, and there is significant demand for diabetic-friendly foods that are nutritious, convenient and functional,” Takatoh said.

Teatis develops a supplement for all consumers interested in low-sugar foods, as well as pre-diabetics, Takatoh said. Teatis’ plant-based powders does not contain chemicals or sweeteners but include a special Japanese ingredient such as brown seaweed extract (Arame) that is proven to suppress the absorption of sugar from the intestinal tract and reduce blood sugar levels. The low-sugar powder can be made into teas, lattes or added to smoothies.

Oviva grabs $80M for app-delivered healthy eating programs

The US meal placement market size for diabetes is estimated at $5 billion while the US consumer packaged foods market for diabetes is approximately $300 billion, Takatoh said.

“We combine food science and technology to solve problems for diabetics through food products and telehealth,” Takatoh said.

With its plan on building out a comprehensive one-stop shop for diabetic health, Teatis will launch a Registered Dietitian platform, Teatis RD on Demand, this month, to offer a full-service such as food products, telehealth, and recipes, for those battling diabetes.

Teatis RD on Demand will provide private, 1-on-1 sessions with registered dietitians. It will start at $29 per 30 minutes, which is a reduced cost, versus traditional offline appointments that cost $150 per 30 minutes, and Teledoc, which costs $90 per 30 minutes, according to Takatoh.

“Many existing players in space are old companies that don’t have digital competency and data-driven production methods. Mr. Takatoh is a proven serial entrepreneur with the qualities and boldness to take over the market…I’m excited to see how Teatis’ great ideas and products will help many people who are suffering from diabetes and other chronic diseases in the future,” Genesia Ventures Manager Shunsuke Sagara said.

Oviva scores $21M Series B to bring its digital diabetes treatment to more of Europe

Plant-based cereal startup OffLimits pours $2.3M into new products

Source Link Teatis, low-sugar superfood powders developer for diabetics, closes seed round

David Barret
David Barret

Related posts:

  1. Hackers are hiring more English speakers to write believable email scams
  2. JBL Quantum 350 looks like a great affordable wireless gaming headset
  3. Canada trade surplus narrowed in July to C$778 million
  4. Life insurers shift to pre-pandemic norms after COVID vaccine roll-outs

Filed Under: News

Reader Interactions

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Primary Sidebar

  • New Species Of Early Human Lived Alongside The Oldest Known Homo, We Still Don’t Fully Know What Long COVID Actually Is, And Much More This Week
  • New AI Model May Predict Success Of Future Fusion Experiments, Saving Money And Fuel
  • Orange Crocodiles, New Human Species, And Death By Meteorite
  • The World’s Largest Terrestrial Carnivore Has Clear Fur And Black Skin, But You Wouldn’t Know It
  • Deep-Sea Explorers Found A Sunken Whale Carcass – And Watched A Wild Banquet Unfold
  • Does Jupiter Have A Solid Core, And If So, How Big Is It?
  • Trump’s Executive Order To Slash Environmental Regulations For Space Launches: We Look At The Risks And Realities
  • An Underwater Volcano Off The US Coast Is Set To Erupt in 2025, Raising Excitement And Worry
  • Hate Doubling Back On Yourself? Psychologists Have Described A New Bias That May Explain Why
  • A New View Of The “Cosmic Grapes” Is Challenging Our Theories Of How Galaxies Form
  • Ann Hodges: The Only Confirmed Person To Be Hit By A Meteorite And Live
  • Massive Offshore Canyon Expedition Discovers Barbie Lobsters, Sea Pigs, And 40 Potential New Species
  • The Pleiades Will Dance With The Moon This Weekend
  • Tennis Player Gets Public Confused With Autograph About The Fermi Paradox
  • Woman Unearths 2.3 Carat Diamond For Her Future Engagement Ring In State Park
  • RFK Jr Wanted A Journal To Retract This Massive Study On Aluminum In Vaccines. It Refused
  • Can You See The Frog In This Photo? Incredible Camouflage Shows Wildlife Survival Strategy
  • Do Crab-Eating Foxes Actually Eat Crabs?
  • Death Valley’s “Racing Rocks” Inspire Experiment To Make Ice Move On Its Own
  • Parasite “Cleanses”: Are We Riddled With Worms Or Is This Just The Latest Bogus Fad?
  • Business
  • Health
  • News
  • Science
  • Technology
  • +1 718 874 1545
  • +91 78878 22626
  • [email protected]
Office Address
Prudour Pvt. Ltd. 420 Lexington Avenue Suite 300 New York City, NY 10170.

Powered by Prudour Network

Copyrights © 2025 · Medical Market Report. All Rights Reserved.

Go to mobile version